Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

futibatinib × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8 Thoracic 3 Sarcoma 3 Tumor-Agnostic 2 Head & Neck 2 Genitourinary 2 Breast 2 Plasma cell 1 Lymphoid 1 Gynecologic 1

Conditions

Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Rituximab 1177 Cyclophosphamide 1105 Vincristine 557 Doxorubicin 498 Etoposide 447 Prednisone 423 Cytarabine 405 fludarabine 400 Methotrexate 361 Dexamethasone 339 fludarabine phosphate 328 Lenalidomide 304 Filgrastim 295 Bendamustine Hydrochloride 235 Radiotherapy 230 venetoclax 222 ibrutinib 214 obinutuzumab 200 Melphalan 191 Peripheral Blood Stem Cell Transplantation 190 Granulocyte Colony-Stimulating Factor 174 Gemcitabine 169 Bortezomib 164 Busulfan 158 Whole-Body Irradiation 155 Mycophenolic Acid 145 Tacrolimus 125 Magnetic Resonance Spectroscopy 123 pegaspargase 122 Specimen Handling 121

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02693535 2026-02-13

TAPUR

American Society of Clinical Oncology

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡